{"log_id": 1088918225343451729, "direction": 0, "words_result_num": 53, "words_result": [{"probability": {"variance": 0.010376, "average": 0.927996, "min": 0.720842}, "location": {"width": 539, "top": 38, "height": 38, "left": 201}, "words": "重人促红素注射液(CHO细)说明书"}, {"probability": {"variance": 2.1e-05, "average": 0.994337, "min": 0.98513}, "location": {"width": 144, "top": 36, "height": 36, "left": 1358}, "words": "页码,2/3"}, {"probability": {"variance": 0.021747, "average": 0.919462, "min": 0.417331}, "location": {"width": 912, "top": 164, "height": 32, "left": 537}, "words": "因此,次使用本品或重新使用本品时,建议先使用少量,确定无异常反应后,再注射"}, {"probability": {"variance": 0.024833, "average": 0.913761, "min": 0.404989}, "location": {"width": 464, "top": 201, "height": 36, "left": 537}, "words": "全量。如发异常,应立即停药并妥处理"}, {"probability": {"variance": 0.032999, "average": 0.858762, "min": 0.390486}, "location": {"width": 893, "top": 249, "height": 29, "left": 534}, "words": "3.心脑血管系统,血压升高、原有的高血压恶化和因高脑病头痛、意识障得"}, {"probability": {"variance": 0.044007, "average": 0.800297, "min": 0.365205}, "location": {"width": 916, "top": 290, "height": 48, "left": 534}, "words": "痉豪发生新光因态红细胞生成注射治疗期应注意并定期观察"}, {"probability": {"variance": 0.043561, "average": 0.871326, "min": 0.367614}, "location": {"width": 587, "top": 322, "height": 43, "left": 534}, "words": "血压变应药并调整降压药的剂量"}, {"probability": {"variance": 0.037574, "average": 0.757014, "min": 0.422811}, "location": {"width": 153, "top": 374, "height": 32, "left": 683}, "words": "着细胞压"}, {"probability": {"variance": 0.007015, "average": 0.947012, "min": 0.682943}, "location": {"width": 507, "top": 374, "height": 29, "left": 923}, "words": "血液粘度可显增高,因此应注意防止血检形成"}, {"probability": {"variance": 0.012263, "average": 0.901419, "min": 0.746685}, "location": {"width": 54, "top": 418, "height": 27, "left": 532}, "words": "5.肝"}, {"probability": {"variance": 0.019274, "average": 0.668826, "min": 0.529996}, "location": {"width": 121, "top": 413, "height": 34, "left": 685}, "words": "C的"}, {"probability": {"variance": 0, "average": 0.896865, "min": 0.896865}, "location": {"width": 50, "top": 459, "height": 27, "left": 562}, "words": "胃"}, {"probability": {"variance": 0.035113, "average": 0.880813, "min": 0.390152}, "location": {"width": 315, "top": 452, "height": 41, "left": 852}, "words": "不、腹泻等情况发生"}, {"probability": {"variance": 0.007141, "average": 0.929043, "min": 0.725416}, "location": {"width": 230, "top": 516, "height": 32, "left": 427}, "words": "【禁忌】1.未控制"}, {"probability": {"variance": 0.000411, "average": 0.98122, "min": 0.942409}, "location": {"width": 118, "top": 518, "height": 32, "left": 711}, "words": "高血压患者"}, {"probability": {"variance": 0.010687, "average": 0.93475, "min": 0.598108}, "location": {"width": 731, "top": 560, "height": 29, "left": 532}, "words": "2.对本品及其他动物细胞衍生物过敏者,对人血清白蛋白过敏者"}, {"probability": {"variance": 0.010917, "average": 0.945917, "min": 0.58454}, "location": {"width": 443, "top": 601, "height": 29, "left": 530}, "words": "3.合并感染者。宜控制感染后再使用本品"}, {"probability": {"variance": 0.006551, "average": 0.957468, "min": 0.6431}, "location": {"width": 1003, "top": 660, "height": 34, "left": 381}, "words": "【注意事项】1.本品用药期间应定期检查红细胞压积用药初期每星期一次:维持期每两星期"}, {"probability": {"variance": 0.020702, "average": 0.927413, "min": 0.383643}, "location": {"width": 914, "top": 704, "height": 32, "left": 532}, "words": "次),注意避免过的红细胞生成(确认红细胞压积在36v1以下),如发现过度的红"}, {"probability": {"variance": 0.029269, "average": 0.896561, "min": 0.478202}, "location": {"width": 413, "top": 745, "height": 29, "left": 534}, "words": "细抱生长,应采取暂停用药等适当理"}, {"probability": {"variance": 0.005755, "average": 0.963806, "min": 0.674059}, "location": {"width": 919, "top": 786, "height": 32, "left": 530}, "words": "2.应用本品有时会引起血清钾轻度升高,应适当调整饮食,若发生血钾升高,应遵医"}, {"probability": {"variance": 0.000115, "average": 0.987287, "min": 0.968757}, "location": {"width": 102, "top": 829, "height": 32, "left": 532}, "words": "调整剂量"}, {"probability": {"variance": 0.017526, "average": 0.931193, "min": 0.503911}, "location": {"width": 916, "top": 871, "height": 32, "left": 528}, "words": "3.对有心肌梗塞、肺梗塞、脑梗塞患者,有药物过敏病史的患者及有过敏烦向的患者应"}, {"probability": {"variance": 0.006539, "average": 0.856127, "min": 0.773337}, "location": {"width": 102, "top": 914, "height": 27, "left": 532}, "words": "恒重给药"}, {"probability": {"variance": 0.014635, "average": 0.925451, "min": 0.585263}, "location": {"width": 889, "top": 953, "height": 32, "left": 557}, "words": "治疗期间因出现有效造血,铁需求量增加。通常会出坝血清钛浓度下降。如果患者"}, {"probability": {"variance": 0.009286, "average": 0.946311, "min": 0.59184}, "location": {"width": 717, "top": 994, "height": 34, "left": 532}, "words": "清铁蛋白低于10mg/ml或转铁蛋白饱和度低于20%,应每日补充铁剂"}, {"probability": {"variance": 0.000307, "average": 0.988085, "min": 0.948464}, "location": {"width": 160, "top": 1037, "height": 29, "left": 528}, "words": "5.运动员慎用"}, {"probability": {"variance": 0.008129, "average": 0.954083, "min": 0.543354}, "location": {"width": 1220, "top": 1097, "height": 34, "left": 228}, "words": "【孕妇及捕乳期妇女用药】孕妇及哺乳期妇女用本剂的安全性尚不明确,不宜对孕妇哺乳期妇女注射本剂。不"}, {"probability": {"variance": 0.010737, "average": 0.964782, "min": 0.557033}, "location": {"width": 560, "top": 1138, "height": 32, "left": 532}, "words": "得已时在判断治疗利益大于危险性的情况下才能使用"}, {"probability": {"variance": 0.018142, "average": 0.926296, "min": 0.582184}, "location": {"width": 525, "top": 1198, "height": 32, "left": 377}, "words": "【儿童用药】对儿童使用本剂的安全性尚不明确"}, {"probability": {"variance": 0.012658, "average": 0.950527, "min": 0.361023}, "location": {"width": 1074, "top": 1259, "height": 34, "left": 374}, "words": "【老年用药】高龄者应用本品时,因其生理机低下,多有高血压和循坏统疾病井发症:在使"}, {"probability": {"variance": 0.016497, "average": 0.919602, "min": 0.517616}, "location": {"width": 772, "top": 1300, "height": 32, "left": 530}, "words": "用本品时要注意频繁菌测压及红细胞压积,并适当调整用药剂量与次数"}, {"probability": {"variance": 0.008834, "average": 0.947542, "min": 0.656239}, "location": {"width": 893, "top": 1355, "height": 34, "left": 326}, "words": "【药物相互作用】叶酸或维生素12不足会降低本品疗效,严重铝过多也会影响疗效"}, {"probability": {"variance": 0.000238, "average": 0.991111, "min": 0.945597}, "location": {"width": 427, "top": 1417, "height": 32, "left": 374}, "words": "【药物过量】尚无实验数据及可靠文献"}, {"probability": {"variance": 0.000491, "average": 0.985956, "min": 0.937205}, "location": {"width": 134, "top": 1481, "height": 29, "left": 374}, "words": "【药理毒理】"}, {"probability": {"variance": 4e-06, "average": 0.996073, "min": 0.994004}, "location": {"width": 102, "top": 1513, "height": 29, "left": 530}, "words": "药理作用"}, {"probability": {"variance": 0.014836, "average": 0.930738, "min": 0.55357}, "location": {"width": 893, "top": 1552, "height": 38, "left": 528}, "words": "促红素(EPO)是由肾脏分泌的一种活性塘蛋白,作用于骨髓中红系造血祖细胞(CFU-E)"}, {"probability": {"variance": 0.024376, "average": 0.893535, "min": 0.40222}, "location": {"width": 930, "top": 1593, "height": 38, "left": 528}, "words": "能促进其增殖、分化,本品为重组人促红素(rhEP0),与天产品相比,生物学作用在体"}, {"probability": {"variance": 0.019826, "average": 0.941204, "min": 0.384077}, "location": {"width": 916, "top": 1636, "height": 36, "left": 528}, "words": "内、外草本一致,药效学试验提示,本品可增加红系造血细胞的集落生成率,临床上"}, {"probability": {"variance": 0.016257, "average": 0.947978, "min": 0.422015}, "location": {"width": 489, "top": 1682, "height": 29, "left": 528}, "words": "对慢性肾功能衰竭性贫血者也表现出该作用"}, {"probability": {"variance": 0.003096, "average": 0.94122, "min": 0.880613}, "location": {"width": 100, "top": 1723, "height": 27, "left": 528}, "words": "毒理研究"}, {"probability": {"variance": 0.02301, "average": 0.929031, "min": 0.360833}, "location": {"width": 889, "top": 1760, "height": 41, "left": 528}, "words": "重复给药毒性:大鼠连续4周、13周及52周静肽注射或腔注射本品,剂量分别为0"}, {"probability": {"variance": 0.014883, "average": 0.944183, "min": 0.385674}, "location": {"width": 919, "top": 1801, "height": 43, "left": 530}, "words": "20、10IU/kg/日以上时,可见白本品药理作用引起的造功能亢进且长期给药会出现"}, {"probability": {"variance": 0.017626, "average": 0.933208, "min": 0.400601}, "location": {"width": 932, "top": 1845, "height": 43, "left": 525}, "words": "骨纤维化。出生后4天的大鼠连2天皮下注射本品,剂量为80IU/kg/日以上时,可见"}, {"probability": {"variance": 0.030046, "average": 0.897537, "min": 0.373983}, "location": {"width": 925, "top": 1888, "height": 38, "left": 525}, "words": "造血功能亢进:剂量4001/kg/日以上时,可见骨髓纤维化和骨形成的结构变化。犬连"}, {"probability": {"variance": 0.011272, "average": 0.930974, "min": 0.635784}, "location": {"width": 928, "top": 1929, "height": 41, "left": 528}, "words": "续4周、13周及52周静脉注射本品,剂量分别为200,1C0、20IU/kg/日以上时,可见造血"}, {"probability": {"variance": 0.034717, "average": 0.902899, "min": 0.390317}, "location": {"width": 635, "top": 1973, "height": 32, "left": 528}, "words": "功能亢进。且长期给药会出现骨髓纤维化及的结构变化"}, {"probability": {"variance": 0.034662, "average": 0.874138, "min": 0.355707}, "location": {"width": 896, "top": 2011, "height": 41, "left": 525}, "words": "传毒性:本品体外Aes中国仓鼠细遗传性试验小鼠微核试验结果均为阴性"}, {"probability": {"variance": 0.018207, "average": 0.941393, "min": 0.392483}, "location": {"width": 836, "top": 2053, "height": 38, "left": 525}, "words": "生殖毒性:观察了妊娠期、器形成期、围产及没乳期静脉注行本品20、100"}, {"probability": {"variance": 0.017808, "average": 0.911955, "min": 0.502496}, "location": {"width": 930, "top": 2096, "height": 38, "left": 528}, "words": "500IU/kg/日对雌性大鼠生殖功能的影响,结果可见胎仔休重减轻,骨化及仔鼠发育抑制"}, {"probability": {"variance": 0.015886, "average": 0.934033, "min": 0.529243}, "location": {"width": 930, "top": 2135, "height": 43, "left": 528}, "words": "等作用,但未见致略作用。家兔在器官形成期静注射本品剂量达5001U/kg/日时,未见"}, {"probability": {"variance": 0.003753, "average": 0.945986, "min": 0.632872}, "location": {"width": 829, "top": 2261, "height": 36, "left": 185}, "words": " http: //125.35. 5. 41/wan/servlet/Viewdetailinsservlet"}, {"probability": {"variance": 0.004137, "average": 0.963003, "min": 0.80316}, "location": {"width": 130, "top": 2272, "height": 27, "left": 1351}, "words": "2014--2-2"}], "language": 3}